首页> 外文期刊>Indian journal of clinical biochemistry >Screening and Assessment of Bone Health in Indian Women Using an Indigenous ELISA of Human Osteocalcin a Bone Turnover Marker
【24h】

Screening and Assessment of Bone Health in Indian Women Using an Indigenous ELISA of Human Osteocalcin a Bone Turnover Marker

机译:使用人骨质细胞的土着ELISA骨周转标记筛选和评估印度女性骨骼健康

获取原文
           

摘要

Osteoporosis a major public health problem of the elderly, is associated with substantial morbidity and socio economic burden. The aim of the study was to screen women with low bone mass using the indigenously developed Osteocalcin (OC) ELISA kit and compare it with commercial ELISA kit and evaluate. The diagnostic potential of the assay was assessed in 359 samples from neighboring tertiary care hospitals over a period of 2?years. OC levels were estimated by the developed indigenous assay in samples, correlated with the Bone Mineral Density (BMD) measurements and compared by a commercial ELISA kit. On the basis of T-scores the women were stratified into Normal and case groups as Osteopenia and Osteoporosis. The serum biochemical parameters calcium and phosphorus were estimated on an auto-analyzer. To compare two different assays Bland–Altman plot and Deming linear regression analysis was performed. The prevalence of Osteopenia was high (56%) and Osteoporosis (13%) in the healthy Indian women aged 21–65?years with significant differences in OC levels in normal and women with low bone mass. Good correlation (p??0.0001) in the OC levels by the two assays was observed. Cut off limits established earlier with indigenous assay (11.9?ng/mL and 14.9?ng/mL) for Osteopenia and Osteoporosis were similar to those with the commercial kit (13.2?ng/mL and 16.8?ng/mL) respectively. The diagnostic sensitivity, specificity and accuracy of the OC prototype was??85%. The cost effective OC prototype can be used in screening and management of Indian women with low bone mass.
机译:骨质疏松症是老年人的主要公共卫生问题,与大量发病率和社会经济负担有关。该研究的目的是使用本发明开发的骨钙素(OC)ELISA试剂盒筛选骨质骨块的妇女,并将其与商业ELISA套件进行比较并评估。分析的诊断潜力于359名来自邻近的三级护理医院的359个样本中的2年来评估。通过样品中发育的本土测定估计OC水平,与骨矿物密度(BMD)测量相关并由商业ELISA试剂盒进行相关性。基于T分数的基础,将妇女分解成正常和案例群,作为骨质增长和骨质疏松症。在自动分析仪上估计血清生物化学参数钙和磷。为了比较两种不同的测定,进行平坦 - altman图,并进行了Deming线性回归分析。骨凋亡的患病率高(56%)和骨质疏松症(56%),健康的印度女性在21-65岁以下的骨质症(13%),骨骼和骨质骨骼癌症中的癌症水平显着差异。观察到两种测定的OC水平的良好相关性(P?<β0101)。对骨质增生和骨质疏松症提前建立的截止限值(​​11.9≤ML和14.9μg/ mL)分别与商业试剂盒(13.2〜Ng / ml和16.8〜Ng / ml)相似。 OC原型的诊断敏感性,特异性和准确性?>?85%。成本效益的OC原型可用于骨块低的印度女性的筛选和管理。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号